Spontaneous recovery from suppressed B cell production and proliferation caused by intrauterine azathioprine exposure in the fetal period

Abstract

Get full access to this article

View all access options for this article.

References

Gotestam Skorpen

Hoeltzenbein

Tincani

et al.

The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis 2016; 75: 795–810.

Pilarski

Yacyshyn

Lazarovits

. Analysis of peripheral blood lymphocyte populations and immune function from children exposed to cyclosporine or to azathioprine in utero. Transplantation 1994; 57: 133–144.

Wiles

Chandiramani

Jiwani

Nelson-Piercy

. A retrospective study of anaemia in neonates exposed to thiopurines in utero. Gut 2016; 65: 886–887.

Jharap

de Boer

Stokkers

et al.

Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease. Gut 2014; 63: 451–457.

Gardiner

Gearry

Roberts

Zhang

Barclay

Begg

. Comment: Breast-feeding during maternal use of azathioprine. Ann Pharmacother 2007; 41: 719–720. author reply 720.